KIT and thymoma: In this study, 3 of 19 (16%) thymomas exhibited missense variants of uncertain clinical significance in ERBB2 [p.(Ser703Arg)], KIT [p.(Ile690Val)], and FOXL2 [p.(Pro157Ser)].